Clinical Takeaway
A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use concerns during the high-risk college transition period. Digital tools like this are being evaluated as scalable, accessible alternatives or supplements to traditional campus mental health services. Results from this trial provide evidence-based guidance on whether app-based interventions can meaningfully move the needle on student wellbeing and substance use outcomes.
#4 Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.
Citation: Vereschagin Melissa et al.. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.. Journal of medical Internet research. 2024. PMID: 38536225.
Design: 5 Journal: 0 N: 3 Recency: 1 Pop: 2 Human: 1 Risk: 0
This randomized controlled trial provides evidence on the clinical efficacy of a student-codeveloped mobile intervention for concurrent mental health and substance use disorders, a prevalent comorbidity in the university population that traditionally receives fragmented treatment. The scalable digital delivery model addresses a critical gap in accessible mental health care for young adults during a high-risk developmental period when early intervention can prevent progression to chronic conditions. If effective, the findings support integration of digital therapeutics into university health systems and establish a replicable framework for app-based intervention design in this population.
Abstract: BACKGROUND: University attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students. OBJECTIVE: This study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students. METHODS: A 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome. RESULTS: In total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measure
🧠 While the Minder app represents a thoughtful, student-centered approach to addressing mental health and substance use in a high-risk transition period, we should note that the abstract provided is incomplete and lacks critical efficacy data needed for clinical evaluation. Digital interventions show genuine promise for scalability and accessibility in university populations, yet their real-world effectiveness depends heavily on engagement rates, adherence patterns, and whether improvements persist beyond the study period—factors often difficult to control in open digital environments. Cannabis use specifically among university students warrants particular attention given this population’s vulnerability to problematic use patterns and potential impacts on developing brains, and any digital intervention should ideally incorporate substance-specific screening and motivational feedback rather than generic mental health support. Until we see the full results, effect sizes, and longer-term follow-up data, clinicians should view such apps as potentially useful adjuncts to standard care rather than replacements for direct assessment and intervention. For your practice, consider recommending digital mental health tools to students as part of a broader support strategy
| |